1 |
亚洲急危重症协会中国腹腔重症协作组.重症急性胰腺炎镇痛治疗中国专家共识(2022版)[J].中华消化外科杂志,2022,21(12):1499-1509.
|
2 |
Fan N, Hu Y, Shen H, et al. Compositional and drug-resistance profiling of pathogens in patients with severe acute pancreatitis: a retrospective study[J]. BMC Gastroenterology, 2020, 20 (1): 405.
|
3 |
Qu C, Wei M, Li WQ. Extrapancreatic and pancreatic infection in acute pancreatitis[J]. Eur J Gastroenterol Hepatol, 2021, 33 (4): 598-599.
|
4 |
党晓燕,丁新爱,孙媛.重症急性胰腺炎继发感染性胰腺坏死患者细胞间黏附分子-1、降钙素原、血清C反应蛋白的表达及临床意义[J].解放军医药杂志,2018,30(8):54-57.
|
5 |
Tian H, Chen L, Wu X, et al. Infectious complications in severe acute pancreatitis: pathogens, drug resistance, and status of nosocomial infection in a university-affiliated teaching hospital[J]. Dig Dis Sci, 2020, 65 (7): 2079-2088.
|
6 |
王琦琦,程亚丽,周灿灿,等.急性胰腺炎患者的临床特征分析[J].中华消化外科杂志,2023,22(S1):38-43.
|
7 |
Huang H, Chen W, Tang G, et al. Optimal timing of contrast-enhanced computed tomography in an evaluation of severe acute pancreatitis-associated complications[J]. Exp Ther Med, 2019, 18 (2): 1029-1038.
|
8 |
Siriwardena AK, Windsor J, Zyromski N, et al. Standards for reporting on surgery for chronic pancreatitis: a report from the International Study Group for Pancreatic Surgery (ISGPS)[J]. Surgery, 2020, 168 (1): 101-105.
|
9 |
中华医学会消化病学分会胰腺疾病学组,中华胰腺病杂志编辑委员会,中华消化杂志编辑委员会.中国急性胰腺炎诊治指南(2019年,沈阳)[J].中华消化杂志,2019,39(11):721-730.
|
10 |
中华医学会外科学分会胰腺外科学组.急性胰腺炎诊治指南(2014版)[J/CD].中华肝脏外科手术学电子杂志,2015,14(3):195-196.
|
11 |
郭子皓,郝建宇.急性胰腺炎感染的诊治进展及国内外指南解读[J].中国实用内科杂志,2014,34(9):850-852.
|
12 |
Tian F, Li H, Wang L, et al. The diagnostic value of serum C-reactive protein, procalcitonin, interleukin-6 and lactate dehydrogenase in patients with severe acute pancreatitis[J]. Clin Chim Acta, 2020 (510): 665-670.
|
13 |
Long D, Wang Y, Wang H, et al. Correlation of serum and ascitic fluid soluble form urokinase plasminogen activator receptor levels with patient complications, disease severity, inflammatory markers, and prognosis in patients with severe acute pancreatitis[J]. Pancreas, 2019, 48 (3): 335-342.
|
14 |
Tan C, Yang L, Shi F, et al. Early systemic inflammatory response syndrome duration predicts infected pancreatic necrosis[J]. J Gastrointest Surg, 2020, 24 (3): 590-597.
|
15 |
赵倩,张美玉,季萍,等.细胞间黏附分子-1在CD4+T细胞辅助B细胞产生抗体中的作用和临床意义[J].上海交通大学学报(医学版),2021,41(5):588-594.
|
16 |
Gao HK, Zhou ZG, Li Y, et al. Toll-like receptor 4 Asp299Gly polymorphism is associated with an increased risk of pancreatic necrotic infection in acute pancreatitis: a study in the Chinese population[J]. Pancreas, 2007, 34 (3): 295-308.
|
17 |
牛文一,李明瑛,万勇敢.活动性肺结核患者外周血CD4+T细胞中TLR4与血清IFN-γ、IL-4的关系[J].临床肺科杂志,2018,23(8):1509-1512,1519.
|
18 |
王睿琪,王平,杜广胜. HMGB1通过TLR4促进心肌缺血损伤并调节脾脏CD4+、CD8+T细胞和Th17细胞比例[J].细胞与分子免疫学杂志,2018,34(9):794-799.
|
19 |
Ren Y, Wang R, Jiang L, et al. Regulatory effects of Toll-like receptor 4 knockout on CD4+ and CD8+ T lymphocytes and interleukin-17 during myocardial ischemia[J]. Ann Clin Lab Sci, 2020, 50 (6): 761-768.
|
20 |
陈志强,马娜娜,赵潇,等.细菌外膜囊泡肿瘤疫苗对胰腺癌小鼠肿瘤细胞增殖和CD8+ T细胞浸润的影响.中华消化外科杂志,2022,21(4):530-536.
|
21 |
郜亮,冯向先. Toll样受体4在恶性黑色素瘤中的表达及其介导肿瘤免疫逃逸的机制[J].中华实验外科杂志,2015,32(6):1387-1390.
|
22 |
陈娟,付虹霞.恩度联合放、化疗对中晚期宫颈癌疗效及CD4+T细胞平衡失调的影响[J].肿瘤药学,2020,10(6):709-713.
|
23 |
姚斌,李敏,庞英.草分枝杆菌对哮喘小鼠CD4+CD25+调节性T细胞和Th17细胞平衡的影响[J].中国当代儿科杂志,2013,15(11):1018-1022.
|
24 |
化维,朱嫚嫚,范璐璐,等.内质网应激肝癌细胞通过外泌体-Toll样受体4信号途径促进巨噬细胞M2极化[J/OL].中国药理学通报,2021,37(7):1008-1015.
|